Evidence map›Paper›PMID 30808769›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Plasma lipidome reveals critical illness and recovery from human Ebola virus disease.

J E Kyle, K E Burnum-Johnson, J P Wendler, A J Eisfeld, Peter J Halfmann, Tokiko Watanabe, Foday Sahr, R D Smith, Y Kawaoka, K M Waters and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Utility of Protein Markers in COVID-19 Patients.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ebola virus-like particles reprogram cellular metabolism.Journal of molecular medicine (Berlin, Germany) · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

J E KyleBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352; jennifer.kyle@pnnl.gov Thomas.Metz@PNNL.gov.ORCID 0000-0002-9282-9005
K E Burnum-JohnsonBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352.ORCID 0000-0002-2722-4149
J P WendlerBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352.
A J EisfeldDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI 53711.
Peter J HalfmannDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI 53711.
Tokiko WatanabeDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, 108-8639 Tokyo, Japan.
Foday Sahr34th Regimental Military Hospital at Wilberforce, Freetown, Sierra Leone.
R D SmithBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352.
Y KawaokaDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI 53711.
K M WatersBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352.
T O MetzBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352; jennifer.kyle@pnnl.gov Thomas.Metz@PNNL.gov.
Pacific Northwest National Laboratory · USUniversity of Wisconsin–Madison · USThe University of Tokyo · JP

Funding

Systems Biology Identifies Restriction Factors for West Nile VirusU19AI106772 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LIVNY, MIRON · 2013 to 2017
$26.1M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
NIAID NIH HHS U19 AI106772NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

Ebola virus disease (EVD) often leads to severe and fatal outcomes in humans with early supportive care increasing the chances of survival. Profiling the human plasma lipidome provides insight into critical illness as well as diseased states, as lipids have essential roles as membrane structural components, signaling molecules, and energy sources. Here we show that the plasma lipidomes of EVD survivors and fatalities from Sierra Leone, infected during the 2014-2016 Ebola virus outbreak, were profoundly altered. Focusing on how lipids are associated in human plasma, while factoring in the state of critical illness, we found that lipidome changes were related to EVD outcome and could identify states of disease and recovery. Specific changes in the lipidome suggested contributions from extracellular vesicles, viremia, liver dysfunction, apoptosis, autophagy, and general critical illness, and we identified possible targets for therapies enhancing EVD survival.

Indexed as

AdolescentAdultChildCritical IllnessDisease OutbreaksEbolavirusFemaleGene Expression RegulationHemorrhagic Fever, EbolaHumansLipid MetabolismLipidsMaleSierra LeoneYoung AdultLipidscritical illnessEbolalipidomicsmass spectrometrytherapies

Identifiers

PMID30808769
PMCPMC6397561
OpenAlexW2913107344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.